• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌患者血清和尿液羟脯氨酸水平的研究。

Study of serum and urine hydroxyproline level of patients with prostatic cancer.

作者信息

Romics I, Lengyel L

出版信息

Eur Urol. 1984;10(6):395-7. doi: 10.1159/000463842.

DOI:10.1159/000463842
PMID:6529955
Abstract

The serum and urine hydroxyproline levels of patients with prostatic cancer were regularly studied for 30 months. Bone metastases were found in 4 patients at the beginning of the study; metastases formed in 8 patients during the test period, and in 9 patients no metastases formed during the study. At the time of X-ray diagnosis of metastasis, significantly higher serum and urine hydroxyproline levels and enzymatic phosphatase were found, but in the tests performed 3 months earlier, in spite of the negative X-ray results, the hydroxyproline results differed significantly from the reference values. The above findings support the use of the hydroxyproline test for the diagnosis of metastases.

摘要

对前列腺癌患者的血清和尿液羟脯氨酸水平进行了为期30个月的定期研究。研究开始时在4例患者中发现骨转移;在测试期间有8例患者出现转移,9例患者在研究期间未出现转移。在X线诊断转移时,发现血清和尿液羟脯氨酸水平及酶性磷酸酶显著升高,但在3个月前进行的检测中,尽管X线结果为阴性,但羟脯氨酸结果与参考值有显著差异。上述发现支持使用羟脯氨酸检测来诊断转移。

相似文献

1
Study of serum and urine hydroxyproline level of patients with prostatic cancer.前列腺癌患者血清和尿液羟脯氨酸水平的研究。
Eur Urol. 1984;10(6):395-7. doi: 10.1159/000463842.
2
Urinary hydroxyproline excretion as a marker of bone metastasis in prostatic cancer.
Tohoku J Exp Med. 1982 Aug;137(4):461-2. doi: 10.1620/tjem.137.461.
3
[Urinary and serum hydroxyproline in the diagnosis of bone metastases of prostatic cancer].
Schweiz Med Wochenschr. 1981 Feb 21;111(8):246-51.
4
Urine hydroxyproline excretion--a marker of bone metastases in prostatic carcinoma.尿羟脯氨酸排泄——前列腺癌骨转移的一个标志物。
Br J Urol. 1977;49(7):711-6. doi: 10.1111/j.1464-410x.1977.tb04558.x.
5
Hydroxyproline in the early diagnosis of bone metastases in prostatic cancer.
Scand J Urol Nephrol. 1974;8(2):91-5. doi: 10.3109/00365597409132111.
6
Urinary hydroxyproline in healthy patients and in prostate patients with and without bone metastases.
Curr Probl Clin Biochem. 1979(9):249-56.
7
[Use of urinary hydroxyproline excretion as a marker of bone metastases in prostatic cancer (1)].
Hinyokika Kiyo. 1985 Dec;31(12):2119-25.
8
Serial spot hydroxyproline/creatinine ratios in metastatic prostatic cancer.转移性前列腺癌患者连续的尿羟脯氨酸/肌酐比值
J Urol. 1983 Feb;129(2):319-23. doi: 10.1016/s0022-5347(17)52076-5.
9
[Urinary hydroxyproline excretion as a marker of bone metastasis in prostatic cancer (II): Correlation between extent of metastatic lesions in whole body bone scintigraphy of patients with prostatic cancer and tumor markers in blood and urine].
Nihon Hinyokika Gakkai Zasshi. 1984 Jan;75(1):53-8. doi: 10.5980/jpnjurol1928.75.1_53.
10
[Clinical evaluation of bone turnover in patients with bone metastasis of various cancer of urogenital tract].
Nihon Hinyokika Gakkai Zasshi. 1990 Aug;81(8):1190-6. doi: 10.5980/jpnjurol1989.81.1190.